Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance.
Clin Microbiol Infect
; 26(9): 1266-1268, 2020 Sep.
Article
in En
| MEDLINE
| ID: mdl-32240711
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Quinoxalines
/
Sulfonamides
/
Benzimidazoles
/
Proline
/
Hepatitis C
/
Hepacivirus
/
Cyclopropanes
/
Lactams, Macrocyclic
/
Sofosbuvir
Type of study:
Diagnostic_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Microbiol Infect
Journal subject:
DOENCAS TRANSMISSIVEIS
/
MICROBIOLOGIA
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: